Male erectile dysfunction
ICD-10 F52.2; N48.4 · ICD-11 HA01.1

Erectile Dysfunction Management in Patients Using Organic Nitrates or Nicorandil

Clinical scenario

This protocol applies to male patients with erectile dysfunction who are concurrently using organic nitrates or nicorandil — a specific situation that rules out the most widely prescribed class of ED treatments.

An absolute contraindication to PDE5Is is the concomitant use of any form of organic nitrate or nitric oxide donors, including recreational use of amyl nitrite or nitrate (poppers). Concurrent use of nicorandil and PDE5Is is likewise contraindicated due to the nitric oxide donating properties of nicorandil.

Approach overview

Management begins with lifestyle modifications targeting cardiovascular risk factors, alongside which several non-PDE5 inhibitor treatment pathways are available — options that can be used safely in patients for whom PDE5Is are contraindicated. The full structured regimen details the specific alternatives and the sequence in which they are considered.

Treatment goal
Achievement of erection with rigidity sufficient for satisfactory intercourse.
Instant Access to Structured Evidence-Based Regimens

References

  1. An absolute contraindication to PDE5Is is the concomitant use of any form of organic nitrate or nitric oxide donors, including recreational use of amyl nitrite or nitrate (poppers).
  2. Concurrent use of nicorandil and PDE5Is is contraindicated due to the potential of the nitric oxide donating properties of nicorandil to increase cGMP levels.
  3. Initiate lifestyle changes and risk factor modification prior to, or at the same time as, initiating erectile dysfunction (ED) treatments.
  4. Efficacy is defined as an erection, with rigidity, sufficient for satisfactory intercourse.
View source ↗